Literature DB >> 12056643

Preliminary evaluation of mast cells and angiogenesis processes in experimental fibrosarcoma.

B Sawicki1, I Kasacka, L Chyczewski.   

Abstract

The aim of the study was the evaluation of angiogenesis processes in fibrosarcoma induced by 3-methylcholanthrene (3-Mc) in reference to the number of mast cells (MCs). 76 male Wistar rats were divided into 4 groups: two experimental (E) groups--after injection of 0.2 mg 3-Mc dissolved in olive oil (0.25ml), and 2 control (C) groups. In E1 group, 52 rats were killed after development of the fibrosarcoma; E(2)--10 rats were killed before development of the tumor; C(1)-8 rats received 0.25ml olive oil; C(2)--8 rats received no treatment. Tissue material was fixed in buffered formalin or Carnoy's and Bouin's fluid. Paraffin sections were stained with H+E and Azan methods, and with alcian blue-saphranine and toluidine blue. Immunohistochemical reactions detecting tryptase in MCs were also performed. Angiogenic objects (microvessels and single endothelial cells) were recognized using antibodies against factor VIII (vWF), P selectin (CD-62P), and CD-90. We found a distinct relationship between intensification of neoangiogenesis at the tumor periphery and increased number of MCs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12056643

Source DB:  PubMed          Journal:  Folia Histochem Cytobiol        ISSN: 0239-8508            Impact factor:   1.698


  2 in total

1.  Upregulation of tissue kallikrein, kinin B1 receptor, and kinin B2 receptor in mast and giant cells infiltrating oesophageal squamous cell carcinoma.

Authors:  Z Dlamini; K D Bhoola
Journal:  J Clin Pathol       Date:  2005-09       Impact factor: 3.411

2.  PTX3 Modulates Neovascularization and Immune Inflammatory Infiltrate in a Murine Model of Fibrosarcoma.

Authors:  Tiziana Annese; Roberto Ronca; Roberto Tamma; Arianna Giacomini; Simona Ruggieri; Elisabetta Grillo; Marco Presta; Domenico Ribatti
Journal:  Int J Mol Sci       Date:  2019-09-17       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.